LeDoux’s Tax‑Related Sale at NATL Leaves CEO’s Holdings Stronger, Signals Long‑Term Confidence in Natural Alternatives International Inc.

Insider Activity Snapshot – Natural Alternatives International (NATL) On March 6 2026, CEO and Chairman Mark A. LeDoux sold 3,484 shares of NATL common stock at $2.73 each, a price virtually unchanged from the current market price of $2.75. The transaction was a tax‑liability settlement tied to the vesting of 10,667 restricted shares that were granted on March 7, 2026. The sale leaves LeDoux’s post‑transaction holdings at 156,737 shares, a slight decline from the 176,737 shares reported after his concurrent purchase of 20,000 shares in a restricted‑stock grant (Item 2.00).

What the Transaction Signals for Investors The timing and nature of the sale—purely a tax‑payment mechanism—suggests that LeDoux is not attempting to unload shares for a market‑valuation reason. His holdings remain substantial and have grown steadily over the past weeks, indicating a long‑term commitment to the company’s value proposition. For investors, this pattern of incremental buying combined with tax‑related selling can be seen as a green flag, implying confidence in the business fundamentals. The broader insider activity is modest: CFO Fortin and President‑COO Wolf each executed one sale and one purchase on the same day, while other executives made a handful of purchases in March. No significant divestitures or large block trades appear, so the insider sentiment remains largely neutral.

LeDoux’s Transaction Profile and Strategic Implications LeDoux’s recent activity shows a disciplined approach: weekly purchases ranging from 218 to 532 shares at prices between $2.66 and $2.80, punctuated by the 20,000‑share restricted‑stock grant that will vest over three years. His holdings are spread across several large blocks (481,905; 69,416; 7,200; 800; 7,500 shares) that provide liquidity flexibility without eroding ownership concentration. Historically, his trades have been executed close to the market price, suggesting a “buy‑the‑dip” philosophy rather than opportunistic short‑term speculation. This pattern aligns with a focus on long‑term value creation in a niche consumer‑staple sector, where the company’s low PE and stable product pipeline may appeal to patient capital.

Impact on NATL’s Future Outlook NATL’s recent earnings report showed modest growth, and its price has rebounded 4.96 % in the week leading up to the filing, while the year‑to‑date trend is negative at –19.36 %. LeDoux’s continued stake‑holding and the sizeable restricted‑stock grant signal confidence in the company’s ability to navigate the volatile personal‑care supplement market. For analysts and shareholders, the insider data reinforce a cautious yet optimistic view: the leadership is investing in the business, the stock remains undervalued relative to earnings, and the company’s niche expertise positions it well against broader consumer‑staple competitors. Investors should watch for any future large sales or dividend policy changes, but current insider activity suggests that the leadership’s interests remain closely aligned with shareholder value.